Recombinant Francisella tularensis subsp. mediasiatica Malate dehydrogenase (mdh)

Shipped with Ice Packs
In Stock

Description

Recombinant Expression of F. tularensis subsp. mediasiatica MDH

Table 1: Key Features of Recombinant F. tularensis subsp. tularensis MDH

PropertyValue/DescriptionSource
Gene locusFTT_1413 (hypothetical for mediasiatica)
Protein sequenceMARKKITLVG... (335 amino acids)
Optimal pH6.0 (inferred from Brucella abortus MDH)
Optimal temperature40°C (inferred from B. abortus MDH)
InhibitorsCu²⁺, Zn²⁺, Pb²⁺ (partial inhibition)

Enzymatic Characteristics and Kinetic Parameters

Enzymatic data from Brucella abortus MDH (a close phylogenetic relative) provide a proxy for Francisella MDH activity :

  • Catalytic efficiency: Kₘ = 6.45 × 10⁻³ M for oxaloacetate; Vₘₐₓ = 0.87 mM·L⁻¹·min⁻¹.

  • Thermostability: Retains activity up to 50°C but rapidly inactivated above 60°C.

  • Metal ion sensitivity: Cu²⁺ (100% inhibition), Zn²⁺ (60%), Pb²⁺ (40%) .

Substitutions in catalytic residues (e.g., Arg 89 → Ala) abolish >90% of activity , suggesting similar mechanisms in Francisella.

Role in Bacterial Metabolism and Pathogenesis

MDH is integral to Francisella’s metabolic flexibility:

  • Carbon utilization: Subsp. holarctica preferentially uses glucose via glycolysis, while novicida relies on gluconeogenesis . MDH enables anaplerotic flux into the TCA cycle under nutrient-limited conditions.

  • Virulence linkage: Although not directly implicated in pathogenicity, MDH supports survival in macrophages by maintaining redox balance .

Comparative Analysis Across Subspecies

  • SNP profile: 8 synonymous mutations in mdh compared to subsp. tularensis .

  • Regulatory context: Co-located with genes encoding ClpB (a heat shock protein critical for Type VI secretion system function) .

Implications for Therapeutic Development

  • Drug target potential: MDH’s role in central metabolism makes it a candidate for inhibitors (e.g., metal chelators) .

  • Vaccine design: While MDH is not immunodominant in Francisella, its homologs in Brucella elicit protective antibodies .

Q&A

What is Malate dehydrogenase (mdh) and what is its role in Francisella tularensis subsp. mediasiatica metabolism?

Malate dehydrogenase (mdh) is a critical metabolic enzyme that catalyzes the reversible conversion of malate to oxaloacetate while reducing NAD+ to NADH. In F. tularensis subsp. mediasiatica, this enzyme plays a crucial role in several metabolic pathways:

  • Functions as a key component of the tricarboxylic acid (TCA) cycle

  • Participates in energy production through central carbon metabolism

  • Contributes to maintaining redox balance within bacterial cells

  • May be involved in adaptation to different environmental conditions

The genomic comparisons between Francisella subspecies have revealed distinct patterns of gene conservation and disruption across metabolic pathways, which likely affect the organism's adaptability and virulence . While some metabolic genes show disruption in mediasiatica strains, the mdh gene appears to be conserved, suggesting its essential role in bacterial survival.

How does the genetic structure of mdh in F. tularensis subsp. mediasiatica compare with other Francisella subspecies?

  • F. tularensis subsp. mediasiatica shows high genetic homogeneity despite being geographically restricted

  • Whole genome single nucleotide polymorphism (wgSNP) analysis has assigned mediasiatica strains to specific lineages, with most historical strains belonging to the M.I lineage

  • The mediasiatica subspecies shares certain genetic disruptions with the holarctica subspecies while maintaining distinct characteristics

Researchers should note that while mediasiatica shows limited genetic diversity (with the M.I lineage differing by only 118 SNPs), there may still be subtle variations in metabolic genes like mdh that could affect enzyme function or regulation .

What experimental approaches are recommended for initial characterization of F. tularensis subsp. mediasiatica mdh?

For initial characterization of the mdh gene and its product in F. tularensis subsp. mediasiatica, researchers should consider the following methodological approaches:

  • Genomic analysis:

    • Sequence the mdh gene from multiple mediasiatica isolates

    • Perform comparative analysis with other Francisella subspecies using tools like NCBI BLAST and GView

    • Identify any unique polymorphisms or regulatory elements

  • Expression analysis:

    • Quantify mdh expression levels under different growth conditions

    • Compare expression patterns between mediasiatica and other subspecies

    • Identify potential regulatory factors affecting expression

  • Biochemical characterization:

    • Determine enzyme kinetics (Km, Vmax) for native mdh

    • Assess cofactor requirements and specificity

    • Evaluate pH and temperature optima for activity

These foundational studies will provide essential information for more advanced research on recombinant protein production and functional studies.

What are the optimal expression systems for producing recombinant F. tularensis subsp. mediasiatica Malate dehydrogenase?

Selecting the appropriate expression system is critical for successful production of recombinant F. tularensis subsp. mediasiatica mdh. Consider the following expression platforms:

E. coli-based systems:

  • BL21(DE3) strain for high-yield expression

  • ArcticExpress or Rosetta strains for improved folding of potentially difficult proteins

  • Use pET vector systems with T7 promoter for controlled induction

Alternative expression hosts:

  • Insect cell systems (baculovirus) for proteins requiring post-translational modifications

  • Cell-free expression systems for potentially toxic proteins

Expression optimization parameters:

  • Induction temperature: Lower temperatures (16-20°C) often improve solubility

  • Induction time: Test various induction periods (4-24 hours)

  • Inducer concentration: Titrate IPTG concentration (0.1-1.0 mM)

  • Media composition: Consider specialized media for improved yield

The choice of expression system should be guided by the specific research goals, such as structural studies requiring high purity versus functional assays requiring optimal activity.

What purification strategies yield the highest activity for recombinant F. tularensis subsp. mediasiatica mdh?

A multi-step purification approach is recommended to obtain highly pure and active recombinant mdh:

Initial capture:

  • Immobilized metal affinity chromatography (IMAC) using His-tagged recombinant protein

  • Optimize imidazole concentration in binding and elution buffers to reduce non-specific binding

Intermediate purification:

  • Ion exchange chromatography based on the theoretical pI of the enzyme

  • Optimize salt gradient and pH conditions for maximum resolution

Polishing step:

  • Size exclusion chromatography to remove aggregates and obtain homogeneous protein

  • Consider buffer optimization to maintain enzyme stability during this step

Activity preservation strategies:

  • Include reducing agents (DTT or β-mercaptoethanol) in purification buffers

  • Add glycerol (10-20%) to prevent protein aggregation

  • Consider adding stabilizing cofactors or substrates

  • Maintain cold chain throughout purification

Purification validation:

  • SDS-PAGE for purity assessment

  • Western blot for identity confirmation

  • Activity assays to track enzyme functionality throughout purification

A typical activity yield of 60-80% can be expected with careful optimization of each purification step.

How can researchers address solubility challenges when expressing recombinant F. tularensis subsp. mediasiatica mdh?

Solubility issues are common challenges when expressing recombinant bacterial proteins. For F. tularensis subsp. mediasiatica mdh, consider these strategies:

Genetic modifications:

  • Optimize codon usage for the expression host

  • Create fusion constructs (MBP, SUMO, or GST tags) to enhance solubility

  • Consider truncation constructs if specific domains cause aggregation

Expression conditions optimization:

  • Reduce expression temperature to 16-18°C

  • Use slower induction with lower IPTG concentrations (0.1-0.2 mM)

  • Try auto-induction media for gradual protein expression

Buffer optimization:

  • Screen multiple buffer systems (HEPES, Tris, phosphate) at various pH values

  • Include solubility enhancers:

    • Osmolytes: Glycerol (5-20%), sucrose (5-10%)

    • Salt additives: NaCl (100-500 mM), KCl (50-200 mM)

    • Detergents: Low concentrations of Triton X-100 or CHAPS

Refolding protocols:

  • If inclusion bodies form, develop a refolding strategy using gradual dialysis

  • Consider on-column refolding during IMAC purification

Solubility AdditiveConcentration RangeEffect on mdh Solubility
Glycerol5-20%Prevents aggregation, stabilizes structure
Trehalose50-200 mMEnhances stability during storage
NaCl100-500 mMReduces ionic interactions
Arginine50-500 mMReduces hydrophobic interactions
Reduced/oxidized glutathione1:10 ratio, 1-5 mMFacilitates correct disulfide formation

The optimal conditions will need to be determined empirically for this specific enzyme.

What kinetic parameters are important to determine for recombinant F. tularensis subsp. mediasiatica mdh?

Comprehensive kinetic characterization of recombinant mdh should include:

Basic kinetic parameters:

  • Km and Vmax for both forward and reverse reactions

  • Substrate specificity profile (malate, oxaloacetate, and potential alternate substrates)

  • Cofactor preference (NAD+ vs. NADP+) and binding affinity

Advanced kinetic analysis:

  • pH-rate profiles to determine optimal pH and catalytic residues

  • Temperature dependence and thermostability

  • Effects of potential inhibitors or activators

  • Cooperativity and allosteric regulation assessment

Comparative analysis:

  • Comparison with mdh from other Francisella subspecies to identify functional differences

  • Assessment of kinetic parameters under conditions mimicking host environments

Methodology recommendations:

  • Use spectrophotometric assays monitoring NADH absorbance (340 nm) or fluorescence

  • Implement stopped-flow techniques for rapid kinetics

  • Consider isothermal titration calorimetry (ITC) for thermodynamic binding parameters

This kinetic data will provide insights into potential metabolic adaptations specific to the mediasiatica subspecies compared to other Francisella strains.

How does the structure of F. tularensis subsp. mediasiatica mdh contribute to its functional properties?

Understanding structure-function relationships in mdh provides insights into its biochemical properties:

Structural analysis approaches:

  • X-ray crystallography of recombinant protein (target resolution: <2.0 Å)

  • Cryo-electron microscopy for complex assemblies if mdh forms multimeric structures

  • Homology modeling based on related bacterial mdh structures when experimental structures are unavailable

Key structural features to analyze:

  • Active site architecture and substrate binding residues

  • Cofactor binding domain and specificity determinants

  • Oligomerization interfaces (mdh typically functions as a dimer or tetramer)

  • Unique structural elements compared to other bacterial mdh enzymes

Structure-based functional studies:

  • Site-directed mutagenesis of key catalytic residues

  • Domain swapping experiments with other Francisella subspecies mdh

  • Molecular dynamics simulations to understand conformational changes during catalysis

Unlike some other genes in F. tularensis subsp. mediasiatica that show disruption patterns (such as msrA2, which encodes a peptide methionine sulfoxide reductase), the mdh gene appears to be functionally conserved, suggesting its essential role in bacterial metabolism .

How can researchers effectively study the role of mdh in F. tularensis subsp. mediasiatica pathogenesis?

Investigating the role of mdh in pathogenesis requires multiple complementary approaches:

Genetic manipulation strategies:

  • Gene knockout or knockdown studies (if genetic tools are available)

  • Complementation studies with mdh variants

  • Conditional expression systems to regulate mdh levels

Infection models:

  • Cell culture infection assays to assess intracellular growth

  • Animal models appropriate for F. tularensis studies

  • Ex vivo tissue models to simulate host environments

Metabolic profiling:

  • Metabolomics analysis of wild-type versus mdh-modified strains

  • 13C-labeling studies to track carbon flux through central metabolism

  • Measurement of key metabolite pools during infection

Host-pathogen interaction studies:

  • Assessment of mdh role in resistance to host defense mechanisms

  • Evaluation of mdh contribution to adaptation to host microenvironments

  • Investigation of potential mdh-dependent virulence factors

F. tularensis subspecies show differences in pathogenicity, with the mediasiatica subspecies having an intermediate virulence between the highly pathogenic tularensis and the less virulent holarctica subspecies . The role of metabolic enzymes like mdh in these virulence differences represents an important research area.

What is the potential for developing mdh-targeted inhibitors specific to F. tularensis subsp. mediasiatica?

The development of subspecies-specific mdh inhibitors requires a systematic approach:

Target validation:

  • Confirm essentiality of mdh for F. tularensis subsp. mediasiatica survival

  • Determine if mdh inhibition affects virulence in infection models

  • Identify any redundant metabolic pathways that might bypass mdh function

Inhibitor discovery strategies:

  • Structure-based virtual screening targeting unique features of mediasiatica mdh

  • Fragment-based drug discovery approaches

  • High-throughput screening of compound libraries

  • Rational design based on transition state analogs

Selectivity considerations:

  • Compare with human mdh to identify exploitable differences

  • Evaluate cross-reactivity with mdh from other Francisella subspecies

  • Assess potential effects on beneficial microbiota

Inhibitor characterization:

  • Determine inhibition mechanism (competitive, uncompetitive, mixed)

  • Measure binding kinetics and thermodynamics

  • Evaluate cellular penetration and stability

  • Assess efficacy in infection models

How can recombinant F. tularensis subsp. mediasiatica mdh contribute to diagnostic tool development?

Recombinant mdh can be leveraged for developing diagnostic approaches for mediasiatica:

Antibody-based diagnostics:

  • Generate highly specific antibodies against unique epitopes of mediasiatica mdh

  • Develop ELISA or lateral flow immunoassays for field detection

  • Create immunofluorescence assays for tissue sample analysis

Nucleic acid-based diagnostics:

  • Design PCR primers targeting unique regions of the mediasiatica mdh gene

  • Develop microarray probes for subspecies identification as demonstrated for other Francisella genes

  • Implement isothermal amplification methods for field diagnostics

Activity-based diagnostics:

  • Exploit potential unique catalytic properties of mediasiatica mdh

  • Develop colorimetric or fluorescent activity assays

  • Create biosensor platforms incorporating recombinant mdh

Diagnostic validation:

  • Determine sensitivity and specificity using diverse clinical and environmental samples

  • Compare with existing diagnostic methods

  • Evaluate performance in resource-limited settings

The development of DNA microarray probes has proven valuable for detecting and identifying F. tularensis subspecies , and similar approaches could be applied specifically to the mdh gene for mediasiatica identification.

What metabolic adaptations might be revealed through studying F. tularensis subsp. mediasiatica mdh under different environmental conditions?

Investigating mdh function under various conditions can reveal important metabolic adaptations:

Environmentally relevant conditions to test:

  • Temperature ranges reflecting environmental (4-25°C) versus host (37°C) settings

  • Nutrient limitation scenarios mimicking different ecological niches

  • Oxidative and nitrosative stress conditions simulating host immune responses

  • pH variations reflecting environmental and intracellular conditions

Analytical approaches:

  • Enzyme activity assays under varied conditions

  • Protein stability and folding assessments

  • Metabolic flux analysis using stable isotope labeling

  • Comparative transcriptomics and proteomics

Potential adaptive mechanisms to investigate:

  • Allosteric regulation under stress conditions

  • Post-translational modifications affecting activity

  • Protein-protein interactions modulating function

  • Alternate substrate utilization patterns

The geographic restriction of F. tularensis subsp. mediasiatica may be partly explained by metabolic adaptations involving central carbon metabolism enzymes like mdh. Recent discoveries of new foci in Siberia suggest that mediasiatica may have broader environmental adaptability than previously recognized .

What are common technical challenges in working with recombinant F. tularensis subsp. mediasiatica mdh and how can they be overcome?

Researchers should be prepared to address these common technical challenges:

Expression challenges:

  • Low expression yields: Optimize codon usage and expression conditions

  • Inclusion body formation: Use solubility tags or refold from inclusion bodies

  • Protein toxicity: Use tight expression control or cell-free systems

Purification challenges:

  • Co-purifying contaminants: Implement additional purification steps

  • Activity loss during purification: Include stabilizing agents in buffers

  • Aggregation during concentration: Add anti-aggregation agents or optimize buffer conditions

Activity assay challenges:

  • Interference from assay components: Optimize assay conditions or use alternative detection methods

  • Substrate limitation: Ensure sufficient substrate availability and stability

  • Cofactor competition: Control NAD+/NADH ratios in reaction mixtures

Storage considerations:

  • Avoid repeated freeze-thaw cycles (aliquot protein preparations)

  • Test various storage buffers with different cryoprotectants

  • Consider lyophilization for long-term storage

ChallengeTroubleshooting StrategyExpected Outcome
Low protein solubilityAdd 10% glycerol to lysis buffer30-50% increase in soluble fraction
Activity loss during storageAdd 1 mM DTT and 0.5 mM EDTAMaintain >80% activity for 2 weeks at 4°C
Non-specific binding during IMACInclude 5-10 mM imidazole in binding bufferReduced contaminants with minimal target loss
Aggregation during concentrationAdd 0.05% Tween-20 or 50 mM argininePrevent aggregation up to 5-10 mg/ml
Inconsistent activity measurementsStandardize cofactor quality and concentrationCoefficient of variation <10%

What biosafety considerations should be addressed when working with recombinant proteins from F. tularensis?

While recombinant proteins themselves typically don't present the same biosafety concerns as live organisms, proper precautions should still be taken:

Risk assessment:

  • Recombinant mdh alone is not infectious but contamination with source material is possible

  • F. tularensis is classified as a Tier 1 Select Agent by the CDC, with subspecies-specific considerations

  • Respiratory tularemia is the most severe form with high mortality if untreated

Laboratory containment:

  • Gene cloning and recombinant protein work should be conducted in BSL-2 facilities

  • Any work with viable F. tularensis requires BSL-3 containment

  • Maintain strict separation between recombinant work and viable organism handling

Personnel considerations:

  • Provide specific training on F. tularensis hazards

  • Implement health monitoring for laboratory personnel

  • Consider vaccination for researchers working with viable organisms

Waste management:

  • Decontaminate all materials that contact recombinant proteins

  • Follow institutional guidelines for biological waste disposal

  • Maintain detailed records of all materials and decontamination procedures

These precautions will ensure safe handling of recombinant proteins while minimizing risk to laboratory personnel and the environment.

How can researchers verify that recombinant F. tularensis subsp. mediasiatica mdh accurately represents the native enzyme?

Validating the authenticity of recombinant mdh is crucial for meaningful research outcomes:

Structural verification:

  • Compare mass spectrometry profiles with theoretical predictions

  • Verify correct folding using circular dichroism spectroscopy

  • Assess oligomerization state using size exclusion chromatography or analytical ultracentrifugation

Functional validation:

  • Compare kinetic parameters with native enzyme (if available)

  • Verify expected cofactor preferences and substrate specificity

  • Test sensitivity to known malate dehydrogenase inhibitors

Post-translational modification analysis:

  • Identify any native PTMs using mass spectrometry

  • Determine if PTMs affect enzyme function

  • Consider using eukaryotic expression systems if critical PTMs are identified

Immunological comparison:

  • Generate antibodies against recombinant protein and test cross-reactivity with native enzyme

  • Perform epitope mapping to confirm structural similarity

How might mdh contribute to the unique ecological niche adaptation of F. tularensis subsp. mediasiatica?

The geographic restriction and recent expansion of F. tularensis subsp. mediasiatica raise interesting questions about metabolic adaptation:

Ecological adaptation hypotheses:

  • mdh may have temperature-dependent activity profiles suited to specific environmental conditions

  • Substrate affinity might be optimized for carbon sources available in mediasiatica's ecological niche

  • Regulatory mechanisms may allow for rapid metabolic adjustments to changing environments

Research approaches:

  • Compare mdh sequences from different geographic isolates of mediasiatica

  • Analyze mdh activity under conditions mimicking different ecological niches

  • Investigate potential environmental factors that might select for specific mdh variants

Integration with genomic data:

  • Correlate mdh sequence variations with the M.I lineage classification

  • Assess if SNPs in mdh contribute to the limited genetic diversity observed in mediasiatica

  • Determine if mdh is located near genomic rearrangement breakpoints identified in Francisella subspecies

Understanding mdh's role in ecological adaptation may provide insights into the evolutionary history and distribution patterns of this subspecies.

What comparative analyses between mdh from different Francisella subspecies would be most informative?

Comparative studies can reveal evolutionary relationships and functional adaptations:

Recommended comparative analyses:

  • Sequence analysis across all Francisella subspecies to identify conserved vs. variable regions

  • Structural comparisons to identify subspecies-specific features

  • Kinetic parameter comparison under various environmental conditions

  • Expression pattern analysis in different growth phases and stress conditions

Evolutionary considerations:

  • Assess if mdh shows evidence of selective pressure in different subspecies

  • Determine if horizontal gene transfer has influenced mdh evolution

  • Evaluate if mdh polymorphisms correlate with virulence differences between subspecies

Functional implications:

  • Investigate if subspecies-specific mdh variants show different metabolic capabilities

  • Determine if regulatory differences exist in mdh expression between subspecies

  • Assess if protein-protein interaction networks involving mdh differ between subspecies

Such comparative analyses could help explain the intermediate virulence of mediasiatica between the highly pathogenic tularensis and less virulent holarctica subspecies .

How can systems biology approaches incorporate mdh data to better understand F. tularensis subsp. mediasiatica metabolism?

Integrating mdh research into systems biology frameworks can provide holistic insights:

Multi-omics integration:

  • Combine transcriptomics, proteomics, and metabolomics data to map metabolic networks

  • Position mdh within the context of global metabolic responses to environmental changes

  • Identify metabolic bottlenecks and potential compensatory pathways

Metabolic modeling:

Network analysis:

  • Map protein-protein interaction networks involving mdh

  • Identify regulatory networks controlling mdh expression

  • Compare metabolic network architectures between Francisella subspecies

Evolutionary systems biology:

  • Trace the evolution of central carbon metabolism across Francisella subspecies

  • Identify co-evolving gene clusters that include mdh

  • Relate metabolic network changes to ecological niche adaptations

These approaches can help position mdh within the broader context of F. tularensis subsp. mediasiatica metabolism and potentially explain aspects of this subspecies' unique biology and geographic distribution .

What are the most important knowledge gaps regarding F. tularensis subsp. mediasiatica mdh that should be addressed?

Critical knowledge gaps that warrant investigation include:

Fundamental characterization gaps:

  • Three-dimensional structure of mediasiatica mdh

  • Complete kinetic characterization under physiologically relevant conditions

  • Regulatory mechanisms controlling mdh expression and activity

Functional role gaps:

  • Contribution of mdh to virulence and host adaptation

  • Role in stress responses and environmental persistence

  • Interaction with other metabolic pathways specific to mediasiatica

Technical knowledge gaps:

  • Optimal expression and purification protocols for high-yield production

  • Stabilization strategies for long-term storage and shipping

  • Development of high-throughput activity assays for inhibitor screening

Translational research gaps:

  • Potential of mdh as a therapeutic target

  • Utility as a diagnostic biomarker for mediasiatica

  • Possible applications in synthetic biology or metabolic engineering

Addressing these gaps would significantly advance our understanding of F. tularensis subsp. mediasiatica metabolism and potentially provide new tools for detection and control.

How might advances in structural biology techniques be applied to F. tularensis subsp. mediasiatica mdh research?

Emerging structural biology methods offer new opportunities for mdh research:

Cryo-electron microscopy:

  • Achieve high-resolution structures without crystallization

  • Visualize different conformational states during catalysis

  • Study mdh in complex with interaction partners

Integrative structural biology:

  • Combine X-ray crystallography, NMR, and computational modeling

  • Map conformational dynamics across different timescales

  • Develop more accurate structural models for drug design

Time-resolved structural methods:

  • Capture intermediate states during catalytic cycle

  • Understand structural basis for substrate binding and product release

  • Identify potential allosteric sites for inhibitor development

In-cell structural biology:

  • Study mdh structure in native cellular environment

  • Visualize spatial distribution and organization

  • Identify context-dependent structural features

These advanced methods could reveal unprecedented details about mdh function and provide a foundation for rational inhibitor design targeting unique features of the mediasiatica enzyme.

What collaborative research initiatives would accelerate progress in understanding F. tularensis subsp. mediasiatica mdh?

Progress could be accelerated through these collaborative approaches:

Interdisciplinary collaborations:

  • Structural biologists and computational chemists for structure-based drug design

  • Microbiologists and immunologists to study mdh role in host-pathogen interactions

  • Biochemists and systems biologists to position mdh in metabolic networks

Technology-driven collaborations:

  • Microarray specialists for developing diagnostic tools

  • Genomics experts for comparative analysis across subspecies

  • Protein engineers for developing improved recombinant expression systems

Global research networks:

  • Coordinate sample collection from diverse geographic locations, especially newly identified foci

  • Establish standardized protocols for mdh characterization

  • Create shared databases of sequence, structural, and functional data

Public-private partnerships:

  • Engage biotechnology companies for scaled production of recombinant mdh

  • Collaborate with diagnostic companies on subspecies-specific detection methods

  • Partner with pharmaceutical researchers for inhibitor development

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.